Testing the Investigational Medication Pembrolizumab After Kidney Removal for Patients With Non-Clear Cell Renal Cell Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Pembrolizumab
Related studies linked through entity extraction aliases.
A Study to Investigate GSK5733584 as Maintenance Treatment for Participants With MMRp Endometrial Cancer (BEHOLD-Endometrial02)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Phase 2 Study of Pembrolizumab and Lenvatinib in Anal Squamous Cell Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study of ASP2138 Together With Chemotherapy and Pembrolizumab in Adults With Gastric Cancer
- Status
- RECRUITING
- Phase
- PHASE3
A Study of SYS6010 Plus Anti-PD-(L)-1 Monoclonal Antibody as Adjuvant Therapy in Non-small Cell Lung Cancer (NSCLC)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Enfortumab Vedotin, Pembrolizumab and Quemliclustat for the Treatment of Unresectable Locally Advanced and Metastatic Urothelial Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Enfortumab Vedotin + Pembrolizumab Induction to Spare the Bladder in MIBC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Aglatimagene Besadenovec + Prodrug and Pembrolizumab vs Docetaxel for Stage IV Non-Squamous NSCLC Progressing on Pembrolizumab (AURORA)
- Status
- RECRUITING
- Phase
- PHASE3
Phase 1 Study of a Self-amplifying RNA Vaccine (ITI-5000) in Stage 2-3 Triple Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Study of PM54 in Combination With Immunotherapy in Adult Participants With Advanced Malignancies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
N-3C01 Monotherapy and Combination With PD-(L)1 Inhibitors in Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Olomorasib + Pembrolizumab KRAS G12C Mutant, PD-L1 TPS 1-49% Locally Advanced or Metastatic NSCLC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Sitagliptin With Pembro in RCC and Melanoma
- Status
- RECRUITING
- Phase
- PHASE1
Intensive Locoregional Chemoimmunotherapy, Intradermal Autologous Alpha-DC1 Vaccines, and Systemic Pembrolizumab for Advanced-Stage Ovarian Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study of SKB571 Combination Therapy in Participants With Non-Small Cell Lung Cancer (NSCLC)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A PET Imaging Agent (64Cu-DOTA-Pembrolizumab) for Determining Treatment Response Among Patients With Stage IV Non-small Cell Lung Cancer Receiving Pembrolizumab
- Status
- RECRUITING
- Phase
- PHASE1
Phase 1 Open Label Trial of MST-0312 Alone and in Combination in Subjects With Solid Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
Blood and imagE-guided Optimization of Neoadjuvant Therapy in People With Early Stage Triple-negative Breast cancER - the BETTER Trial
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Pembrolizumab and Lenvatinib in Mismatch Repair Proficient Recurrent Endometrial Cancer After Failure of First-Line Therapy With Platinum-based Doublet and Immunotherapy
- Status
- RECRUITING
- Phase
- PHASE2
A Multicenter, Phase Ib/II Clinical Trial to Evaluate the Efficacy and Safety of Concurrent Combination Therapy of S-531011 Plus Fruquintinib or S-531011 Plus Fruquintinib Plus Pembrolizumab in Patients With MSS/pMMR Colorectal Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2